Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$734.97 20.94 (2.77%) as of 4:30 Fri 5/3


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 703.06(B)
Last Volume: 4,591,951 Avg Vol: 3,291,238
52 Week Range: $423.21 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 435,750 871,420 2,731,506 6,211,418
Total Sell Value $330,574,311 $608,633,217 $2,147,483,647 $2,147,483,647
Total People Sold 2 2 5 6
Total Sell Transactions 5 14 44 89
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 306
  Page 9 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Alvarez Ralph Director   –       •      –    2022-02-22 4 A $239.13 $11,239 D/D 47 51,189     -
   Johnson Kimberly H Director   –       •      –    2022-02-22 4 A $239.13 $9,565 D/D 40 1,133     -
   Yuffa Ilya SVP & President, LLY Intl   •       –      –    2022-02-16 4 AS $242.58 $242,580 D/D (1,000) 11,624 29%     
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONC   •       –      –    2022-02-16 4 D $243.84 $533,034 D/D (2,186) 7,967     -
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONC   •       –      –    2022-02-16 4 OE $0.00 $0 D/D 5,461 10,153     -
   Yuffa Ilya SVP & President, LLY Intl   •       –      –    2022-02-15 4 AS $237.45 $237,450 D/D (1,000) 12,624 34%     
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-09 4 A $243.27 $2,760,628 D/D 11,348 50,352     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2022-02-09 4 A $243.27 $3,001,709 D/D 12,339 152,631     -
   Jonsson Patrik SVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2022-02-09 4 A $243.27 $495,298 D/D 2,036 32,710     -
   Pusey Leigh Ann SVP, Corp. Affairs & Comm.   •       –      –    2022-02-09 4 A $243.27 $1,291,520 D/D 5,309 26,244     -
   Hernandez Edgardo SVP & Pres., Mfg. Operations   •       –      –    2022-02-09 4 A $243.27 $1,322,172 D/D 5,435 20,610     -
   Yuffa Ilya SVP & President, LLY Intl   •       –      –    2022-02-09 4 A $243.27 $796,709 D/D 3,275 13,624     -
   Ricks David A President & CEO   •       •      –    2022-02-09 4 A $243.27 $16,543,333 D/D 68,004 467,783     -
   Norton Johna Senior VP, Global Quality   •       –      –    2022-02-09 4 A $243.27 $801,331 D/D 3,294 30,240     -
   Ashkenazi Anat SVP & CFO   •       –      –    2022-02-09 4 A $243.27 $1,399,289 D/D 5,752 31,427     -
   Weems Alonzo SVP, ERM & CECO   •       –      –    2022-02-09 4 A $243.27 $907,640 D/D 3,731 8,792     -
   Mason Michael B Sr. VP & Pres., Lilly Diabetes   •       –      –    2022-02-09 4 A $243.27 $635,421 D/D 2,612 27,506     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-09 4 A $243.27 $5,493,280 D/D 22,581 78,559     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2022-02-09 4 A $243.27 $716,917 D/D 2,947 8,934     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-01 4 D $245.39 $2,070,355 D/D (8,437) 55,978     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 18,735 64,415     -
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-01 4 D $245.39 $1,031,620 D/D (4,204) 39,004     -
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 9,368 43,208     -
   Ricks David A President & CEO   •       •      –    2022-02-01 4 D $245.39 $6,176,466 D/D (25,170) 399,779     -
   Ricks David A President & CEO   •       •      –    2022-02-01 4 OE $0.00 $0 D/D 56,205 424,949     -
  306 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us